O-59 Quality of life with single agent oral topotecan vs intravenous topotecan in patients with chemosensitive small cell lung cancer (SCLC). An international phase III study
- 31 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S20
- https://doi.org/10.1016/s0169-5002(03)91717-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: